Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 419 clinical trials
The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery

This is a phase III randomized, control, multi-center study of recombinant humanized anti-PD-1 mAb in combination with CTLA4 mAb for injection compared to high-Dose interferon in patients with acral melanoma that has been removed by surgery.

  • 0 views
  • 19 Feb, 2024
  • 1 location
First In Human Study With ABBV-CLS-579 When Given Alone Or In Combination With Programmed Cell Death-1 Inhibitor In Participants With Locally Advanced Or Metastatic Tumors

The purpose of this study is to see how safe and effective ABBV-CLS-579 is when used alone or in combination with programmed cell death protein-1 (PD-1) inhibitors in treating solid cancers. ABBV-CLS-579 is an investigational drug being developed for the treatment of solid tumors. The study has two arms - …

  • 0 views
  • 19 Feb, 2024
  • 1 location
CD19 CAR-T Expressing IL7 and CCL19 Combined With PD1 mAb for Relapsed or Refractory Diffuse Large B Cell Lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin's lymphoma, accounting for 35% of lymphoma. Chimeric antigen receptor T cell (CAR-T) therapy is a new method to treat DLBCL. KTE-C19, published in the New England Medical Journal in December 2017, was used to treat relapsed and refractory B-cell lymphoma. …

non-hodgkin lymphoma
neutrophil count
rituximab
cell transplantation
anthracyclines
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung Cancer

This study will evaluate the efficacy, safety, pharmacokinetics, immunogenicity and biomarkers of RO7198457 plus atezolizumab compared with atezolizumab alone in patients with Stage II-III non-small cell lung cancer (NSCLC) who are circulating tumor DNA (ctDNA) positive following surgical resection and have received standard-of-care adjuvant platinum-doublet chemotherapy.

lung cancer
cancer
hiv test
small cell lung cancer
immunomodulators
  • 0 views
  • 19 Feb, 2024
  • 3 locations
A Novel Combination Oral Agent to Treat Acne Vulgaris,.... (12345)

The purpose of this study is to evaluate a novel, combination product for the treatment of acne vulgaris in females

Accepts healthy volunteers
  • 0 views
  • 07 Dec, 2025
  • 1 location
  • 0 views
  • 19 Feb, 2024
  • 1 location
  • 0 views
  • 10 Jan, 2025
  • 1 location
4.7 val check  

Этот инструмент предназначен для перевода простых предложений; результат может нуждаться в доработке. → Русская клавиатура. → преобразование кириллицы в латиницу. • Deepl: Русский...Этот инструмент предназначен для перевода простых предложений; результат может нуждаться в доработке. → Русская клавиатура. → преобразование кириллицы в латиницу. • Deepl: Русский...Этот инструмент предназначен для перевода простых …

  • 0 views
  • 19 Feb, 2024
  • 5 locations
  • 0 views
  • 19 Feb, 2024
  • 2 locations
  • 0 views
  • 19 Feb, 2024
  • 4 locations